Business description: Galapagos NV

Lakefront Biotherapeutics NV (formerly Galapagos NV) is a biotechnology company built to bring meaningful medicines to patients with serious diseases in therapeutic areas of unmet need. The Company combines world-class deal making expertise with capital to identify, acquire, and advance promising opportunities that have the potential to drive value for patients and shareholders. Applying a modality-agnostic asset selection approach and operational flexibility, Lakefront Biotherapeutics NV prioritizes oncology and immunology & inflammation programs with clear clinical proof-of-concept in emerging areas.

Sales by Activity: Galapagos NV

Fiscal Period: December 2021 (EUR) 2022 (EUR) 2023 (EUR) 2024 (EUR) 2025 (EUR)

Research and Development (R&D)

48Cr 51Cr 24Cr 28Cr 111.22Cr

Geographical breakdown of sales: Galapagos NV

Fiscal Period: December 2021 (EUR) 2022 (EUR) 2023 (EUR) 2024 (EUR) 2025 (EUR)

United States of America

47Cr 41Cr 24Cr 24Cr 108.11Cr

Europe

21.14L 35.52L 16T 3.49Cr 3.11Cr

Executive Committee: Galapagos NV

Manager TitleAgeSince
Chief Executive Officer 53 12/05/2025
Director of Finance/CFO 41 07/07/2025
Chief Operating Officer - 01/06/2026
Chief Tech/Sci/R&D Officer 61 08/06/2026
Investor Relations Contact - -

Composition of the Board of Directors: Galapagos NV

Director TitleAgeSince
Director/Board Member 63 22/10/2019
Director/Board Member 49 07/10/2024
Director/Board Member 53 12/05/2025
Director/Board Member 72 28/07/2025
Director/Board Member 71 28/07/2025
Director/Board Member 59 01/11/2025
Director/Board Member 40 01/11/2025
Chairman 69 28/04/2026

Shareholders: Galapagos NV

NameStocks%Valuation
25.35 %
1,67,07,477 25.35 % 501 M
EcoR1 Capital, LLC
10.92 %
71,93,777 10.92 % 216 M
Van Herk Investments BV
7.035 %
46,35,672 7.035 % 139 M
Niche Asset Management Ltd.
0.1017 %
67,000 0.1017 % 2 M
Saint Olive Gestion SNC
0.0645 %
42,500 0.0645 % 1 M
NameStocks%Valuation
25.35 %
1,67,07,477 25.35 % 501 M
Tang Capital Management LLC
5.745 %
37,85,991 5.745 % 114 M
Madison Avenue Partners LP
5.472 %
36,06,203 5.472 % 108 M
Madison Avenue Partners LP
3.741 %
24,65,179 3.741 % 74 M
EcoR1 Capital, LLC
2.53 %
16,67,119 2.53 % 50 M

Company details: Galapagos NV

Galapagos NV

Industriepark Mechelen Noord

2800, Mechelen

+32 1 534 29 00

http://www.galapagos.com
address Galapagos NV(GLPG)

Other Biotechnology & Medical Research

Change 5-day change 1-year change 3-year change Capi.($)
-0.36%+0.14%-2.06%+14.33% 4.85TCr
-2.71%-2.99%+398.09%+472.12% 3.99TCr
-0.71%+9.45%+27.90%+7.89% 3.87TCr
-0.71%-3.72%+4.94%+52.45% 3.51TCr
-2.41%+1.96%+11.68%+38.17% 2.98TCr
-0.66%-2.73%+35.50%+122.17% 1.61TCr
-0.19%-3.93% - - 1.61TCr
-0.62%+1.23%+2.76%+15.05% 1.36TCr
-3.15%-6.14%-4.82%-36.90% 1.26TCr
Average -1.28%-0.00%+59.25%+85.66% 2.78TCr
Weighted average by Cap. -1.24%+1.16%+76.47%+104.59%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B